Journals / Osteoporoz Dünyasından / 2004 / Cilt: 10 - Sayı: 3

The comparison of effects of alendronate and calcitonin treatment in men with osteoporosis

Erkek osteoporozunda kalsitonin ve alendronat tedavilerinin etkinliklerinin karşılaştırılması

Pages
98–101
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no significant difference of BMD levels of proximal femur when the results were compared either within the groups or between two groups (p>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In recent years, there has been a dramatic increase in research investigating the epidemiology, diagnosis, prevention, and treatment of osteoporosis and fragility fractures in men.
📊
Key Findings & Data:The end of the treatment a significant improvement was found in the BMD levels of the lomber spine in both groups (p<0.001).
💡
Conclusion & Impact:There was no significant difference of BMD levels of proximal femur when the results were compared either within the groups or between two groups (p>0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erkekler · Kalsitonin · Alendronat

Abstract

In recent years, there has been a dramatic increase in research investigating the epidemiology, diagnosis, prevention, and treatment of osteoporosis and fragility fractures in men. This study was performed to compare the effects of alendronate and calcitonin treatment in male osteoporosis. Thirty men with osteoporosis were enrolled in this study. Bone mineral density (BMD) was measured at the proximal femur and lumbar spine by using dual-photon absorptiometry. Thirty men with osteoporosis were randomly divided into two groups. BMD was measured twice as before the treatment and one year later. The end of the treatment a significant improvement was found in the BMD levels of the lomber spine in both groups (p<0.001). There was no significant difference of BMD at the proximal femur when the groups were compared with each other (p>0.05). There was no significant difference of BMD levels of proximal femur when the results were compared either within the groups or between two groups (p>0.05).

Özet

Son yıllarda yapılan araştırmalarda, erkek osteoporozunun epidemiyolojisi, önlenmesi, tanı ve tedavisinde bir artış göze çarpmaktadır. Bu çalışma erkeklerde osteoporoz tedavisi için kullanılan kalsitonin ve alendronatın etkinliğini araştırmak ve bu iki tedavinin etkinliğini karşılaştırmak amacıyla yapıldı. Bu amaçla çalışmaya 30 erkek osteoporozlu hasta dahil edildi ve bunlar rastgele seçilerek 15'er kişilik 2 gruba ayrıldı. Hastalara lomber ve femur bölgesinden kemik mineral yoğunluk (KMY) ölçümü tedavi öncesi ve 1 yıllık tedavi sonrası olmak üzere 2 kez yaptırıldık Lomber KMY açısından gruplar kendi içinde tedavi öncesi, tedavi sonrası kıyaslamada istatistiksel olarak anlamlı bir iyileşme saptandı (p 0.05). Femur KMY ölçümünün tedavi öncesi ve sonrasındaki değerleri hem grup içi ve hem de gruplar arası karşılaştırmasında bir farklılık saptanmadı (p>0.05).

🔖

Cite This Article

GÜRER, G., ŞENDUR, F., ERKEK, A. (2004). The comparison of effects of alendronate and calcitonin treatment in men with osteoporosis. Osteoporoz Dünyasından, Cilt: 10 - Sayı: 3, 98–101. https://ajindex.com/articles/286840

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dawson-Hughes B, Harris SS, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Eng J Med 1997: 337: 670-6
  2. Niguyen TV, Center JR, Eisman JA. Osteoporosis in elderly men and women: Effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res 2000: 15: 322-31
  3. McKay HA, Petit MA, et al. Augmented trochanteric bone mineral density after modified education classes: A randomized school-based exercise intervention study study in prepubescent and early pubescent children. J Pediatr 2000: 136: 156-162
  4. Kujala UM, Kaprio J, et al. Physical activity and osteoporotic hip fracture risk in men. Arch Intern Med 2000: 160: 705-8
  5. Paganini-Hill A, Chao A, et al. Exercise and other factors in the prevention of hip fracture: The Leisure World study. Epidemiology 1991:2: 16-25
  6. Nelson ME, Fiatarone MA, et al. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. JAMA 1994: 272: 1909-1914
  7. Looker AC, Orwoll ES, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997:12: 1761-1768
  8. Tenenhouse A, Joseph L, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: The Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000: 11: 897-904
  9. Harris ST, Gerta BJ, et al. The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endoc Met 1993: 76: 1339-1406
  10. Raisz LG. The osteoporosis revolution. Ann Int Med 1997: 126: 458-462
  11. Olszynski WP, Shawn Davison K, et al. Osteoporosis in Men: Epidemiology, Diagnosis, Prevention, and Treatment. Clin Ther 2004: 26(1):15-28
  12. Jones G, Nguyen T, et al. Symptomatic fracture incidence in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994: 4:277-282
  13. Lunt M, Felsenberg D, et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: The EVOS Study. J Bone Miner Res 1997: 12: 1883-1894
  14. Jackson SA, Tenenhouse A, et al. Vertebral fracture definition from population-based data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 2000: 11: 680-687
  15. O’Neill Tw, Felse